| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0953-6205(03)00034-7 |
| P698 | PubMed publication ID | 12798216 |
| P2093 | author name string | C Gennari | |
| S Gonnelli | |||
| S Martini | |||
| A Montagnani | |||
| G Bellucci | |||
| N Di Paolo | |||
| C Cepollaro | |||
| B Lucani | |||
| M Mangeri | |||
| M B. Franci | |||
| M S. Campagna | |||
| P2860 | cites work | Update on renal osteodystrophy: pathogenesis and clinical management | Q33597900 |
| Biological markers in the diagnosis of the different forms of renal osteodystrophy | Q34028875 | ||
| Clinical use of biochemical markers of bone remodeling: current status and future directions | Q34029394 | ||
| Diagnosis and monitoring of renal osteodystrophy | Q34112383 | ||
| Prediction of bone loss in postmenopausal women | Q34148396 | ||
| Markers of bone turnover for the prediction of fracture risk | Q34148402 | ||
| Markers of bone turnover for monitoring treatment of osteoporosis with antiresorptive drugs | Q34148410 | ||
| Invasive versus non-invasive diagnosis of renal bone disease | Q41571130 | ||
| Biochemical markers for non-invasive diagnosis of hyperparathyroid bone disease and adynamic bone in patients on haemodialysis. | Q50976460 | ||
| Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity. | Q54159612 | ||
| Risk factors for renal osteodystrophy: a multivariant analysis | Q57225537 | ||
| Non-aluminic adynamic bone disease in non-dialyzed uremic patients: a new type of osteopathy due to overtreatment? | Q57226447 | ||
| Renal Osteodystrophy | Q58085748 | ||
| Novel Serum Markers of Bone Resorption: Clinical Assessment and Comparison with Established Urinary Indices | Q60777486 | ||
| The spectrum of bone disease in end-stage renal failure--an evolving disorder | Q70580279 | ||
| Bone metabolism and its assessment in renal failure | Q72828879 | ||
| Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen | Q73451989 | ||
| Quantitative ultrasound in the assessment of skeletal status in uremic patients | Q73455392 | ||
| Biological variability of serum and urinary N-telopeptides of type I collagen in postmenopausal women | Q73632693 | ||
| Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study | Q74141058 | ||
| Serum interleukin-6 in renal osteodystrophy: relationship with serum PTH and bone remodeling markers | Q74605330 | ||
| Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients | Q77373152 | ||
| Serum levels of cross-linked N-telopeptides and aminoterminal propeptides of type I collagen indicate low bone mineral density in elderly women | Q77583471 | ||
| Clinical assessment of collagen cross-linked N-telopeptides as a marker of bone metabolism in patients with primary hyperparathyroidism | Q78205115 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 172-177 | |
| P577 | publication date | 2003-05-01 | |
| P1433 | published in | European Journal of Internal Medicine | Q15716603 |
| P1476 | title | A new serum assay to measure N-terminal fragment of telopeptide of type I collagen in patients with renal osteodystrophy. | |
| P478 | volume | 14 |
| Q46905844 | Correlation between parathyroid hormone, bone alkaline phosphatase and N-telopeptide of type 1 collagen in diabetic and non-diabetic haemodialysis patients |
| Q44911358 | The clinical significance of serum osteocalcin and N-terminal propeptide of type I collagen in predialysis patients with chronic renal failure |
Search more.